[Adult myotonic dystrophy type 1: an update].

Area of Science:

• Neurology
• Genetics
• Internal Medicine

Background:

• Myotonic dystrophy type 1 (DM1), also known as Steinert's disease, is a rare, autosomal dominant inherited myopathy.
• It presents with significant clinical variability and multisystemic consequences, including neurological, cardiac, respiratory, endocrinological, and gastrointestinal issues.
• While patient-reported symptoms like fatigue and mobility problems are common, life-threatening complications such as respiratory compromise and cardiac arrhythmias significantly impact life expectancy.

Purpose of the Study:

• To highlight the critical role of Primary Care physicians in the comprehensive management of Myotonic dystrophy type 1.
• To focus on the detection and management of treatable complications associated with DM1.
• To provide guidance for primary care in coordinating multidisciplinary care for DM1 patients.

Main Methods:

• This work focuses on the diagnostic and management strategies for DM1 complications within a primary care setting.
• It involves reviewing current literature and clinical guidelines relevant to DM1 management.
• The approach emphasizes early detection of serious comorbidities by primary care physicians.

Main Results:

• Primary Care physicians are essential for coordinating care and identifying serious, treatable complications in DM1 patients.
• Early detection of cardiac and respiratory issues can mitigate risks and improve prognosis.
• Effective management of gastrointestinal and neurological symptoms can enhance patient quality of life.

Conclusions:

• The Primary Care physician's role is crucial in the long-term follow-up of Myotonic dystrophy type 1 patients.
• Proactive identification and management of DM1 complications by primary care can significantly improve patient outcomes and life expectancy.
• This work underscores the need for enhanced primary care involvement in managing this complex, multisystemic disease.